Trial intelligence / Profile preview

Topical 20% benzocaine gel for pain reduction during inferior alveolar nerve block injection

IRCT20151017024573N8Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in None comparing 20% benzocaine gel with Placebo gel (2 arms). Primary endpoint: Pain. Started Sep 2019; status: completed.

02

Drugs

benzocaine

Beyond the preview

Go deeper on IRCT20151017024573N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151017024573N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call